Background Childhood epilepsy is a major public health problem worldwide. Even though
anti-seizure medications (ASM) have been demonstrated to control seizures, children with …

BACKGROUND: Epilepsy accounts for 0.5% of the world's disease burden. Around 80% of
these are living in low and middleincome countries. In Ethiopia, the prevalence is 0.6 to 5 …

Background: Epilepsy is a neurological condition that has proven to be a major public health
challenge worldwide, including Zambia. Despite the availability of many treatment …

Background: Anti-epileptic drugs (AEDs) are the primary therapeutic modes for patients with
epilepsy and have been demonstrated to control seizures, which decreases morbidity and …

Epilepsy, once thought to be a disease of evil spirit, is now believed by many as a common
neurologic condition that can be effectively treated by optimal use of anti seizure drugs …

BACKGROUND: Epilepsy can be a large economic burden in countries where appropriate
treatment is not taken due to religious and psychosocial beliefs. The objective of this study …

The aim of this study was to assess epilepsy treatment outcome, adherence to Anti-seizure
medication (ASM), and its predictors among epileptic patients on follow-up at the chronic …

Adherence to antiepileptic drug therapy in people with epilepsy is critical for seizure control.
Poor adherence to epilepsy treatment, on the other hand, is recognized as a worldwide …

Epilepsy is one of the Predominant neurological disorders, which affects over 50 million
people worldwide. Of these, around 85% live in underdeveloped countries, where nine in …

According to the World Health Organization, epilepsy is one of the most common
neurological diseases on the planet, with roughly 50 million people affected by it, including …